VEEA Quote, Financials, Valuation and Earnings

AtlasClear Holdings has a net margin of -65748.98% compared to Veea's net margin of -15.28%. Veea's return on equity of -- beat AtlasClear Holdings's return on equity of --.

Veea has a consensus price target of --, signalling downside risk potential of --. On the other hand AtlasClear Holdings has an analysts' consensus of -- which suggests that it could grow by 81718.17%. Given that AtlasClear Holdings has higher upside potential than Veea, analysts believe AtlasClear Holdings is more attractive than Veea.

Veea has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison AtlasClear Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Veea has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AtlasClear Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Veea pays -- of its earnings as a dividend. AtlasClear Holdings pays out -- of its earnings as a dividend.

Veea quarterly revenues are $50.7K, which are smaller than AtlasClear Holdings quarterly revenues of $2.7M. Veea's net income of -$33.3M is lower than AtlasClear Holdings's net income of -$419.7K. Notably, Veea's price-to-earnings ratio is -- while AtlasClear Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Veea is -- versus 0.03x for AtlasClear Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Aurora Innovation has a net margin of -65748.98% compared to Veea's net margin of --. Veea's return on equity of -- beat Aurora Innovation's return on equity of --.

Veea has a consensus price target of --, signalling downside risk potential of --. On the other hand Aurora Innovation has an analysts' consensus of $7.51 which suggests that it could grow by 8.26%. Given that Aurora Innovation has higher upside potential than Veea, analysts believe Aurora Innovation is more attractive than Veea.

Veea has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Aurora Innovation has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Veea has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aurora Innovation offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Veea pays -- of its earnings as a dividend. Aurora Innovation pays out -- of its earnings as a dividend.

Veea quarterly revenues are $50.7K, which are larger than Aurora Innovation quarterly revenues of --. Veea's net income of -$33.3M is higher than Aurora Innovation's net income of -$193M. Notably, Veea's price-to-earnings ratio is -- while Aurora Innovation's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Veea is -- versus 165.18x for Aurora Innovation. Usually stocks with elevated PS ratios are considered overvalued.

Cantaloupe has a net margin of -65748.98% compared to Veea's net margin of 6.75%. Veea's return on equity of -- beat Cantaloupe's return on equity of 8.34%.

Veea has a consensus price target of --, signalling downside risk potential of --. On the other hand Cantaloupe has an analysts' consensus of $12.50 which suggests that it could grow by 64.26%. Given that Cantaloupe has higher upside potential than Veea, analysts believe Cantaloupe is more attractive than Veea.

Veea has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Cantaloupe has a beta of 1.641, suggesting its more volatile than the S&P 500 by 64.148%.

Veea has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cantaloupe offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Veea pays -- of its earnings as a dividend. Cantaloupe pays out -- of its earnings as a dividend.

Veea quarterly revenues are $50.7K, which are smaller than Cantaloupe quarterly revenues of $73.7M. Veea's net income of -$33.3M is lower than Cantaloupe's net income of $5M. Notably, Veea's price-to-earnings ratio is -- while Cantaloupe's PE ratio is 38.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Veea is -- versus 1.98x for Cantaloupe. Usually stocks with elevated PS ratios are considered overvalued.

Paycor HCM has a net margin of -65748.98% compared to Veea's net margin of -1.14%. Veea's return on equity of -- beat Paycor HCM's return on equity of -1.66%.

Veea has a consensus price target of --, signalling downside risk potential of --. On the other hand Paycor HCM has an analysts' consensus of $22.50 which suggests that it could grow by 0.36%. Given that Paycor HCM has higher upside potential than Veea, analysts believe Paycor HCM is more attractive than Veea.

Veea has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Paycor HCM has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Veea has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Paycor HCM offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Veea pays -- of its earnings as a dividend. Paycor HCM pays out -- of its earnings as a dividend.

Veea quarterly revenues are $50.7K, which are smaller than Paycor HCM quarterly revenues of $180.4M. Veea's net income of -$33.3M is lower than Paycor HCM's net income of -$2M. Notably, Veea's price-to-earnings ratio is -- while Paycor HCM's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Veea is -- versus 5.72x for Paycor HCM. Usually stocks with elevated PS ratios are considered overvalued.